{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:47:57Z","timestamp":1790657277229,"version":"4.1.0"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002657","name":"Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002657","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004006","name":"Istanbul University Scientific Research Projects Unit","doi-asserted-by":"publisher","award":["30961"],"award-info":[{"award-number":["30961"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.gene.2024.148450","type":"journal-article","created":{"date-parts":[[2024,4,7]],"date-time":"2024-04-07T07:35:30Z","timestamp":1712475330000},"page":"148450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Receptor for advanced glycation end products polymorphisms in coronary artery ectasia"],"prefix":"10.1016","volume":"916","author":[{"given":"Ezgi Irmak","family":"Aslan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulcin","family":"Ozkara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Kilicarslan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur Selim","family":"Ser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Bostan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Yildiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca","family":"Diren Borekcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2439-9269","authenticated-orcid":false,"given":"Oguz","family":"Ozturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem","family":"Kucukhuseyin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hulya","family":"Yilmaz Aydogan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2024.148450_b0005","doi-asserted-by":"crossref","first-page":"29240","DOI":"10.3402\/fnr.v59.29240","article-title":"LDL biochemical modifications: a link between atherosclerosis and aging","volume":"59","author":"Alique","year":"2015","journal-title":"Food Nutr. Res."},{"issue":"9","key":"10.1016\/j.gene.2024.148450_b0010","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.amjcard.2004.01.049","article-title":"Relation of coronary artery ectasia to diabetes mellitus","volume":"93","author":"Androulakis","year":"2004","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.gene.2024.148450_b0015","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijcard.2008.05.071","article-title":"Pathogenetic mechanisms of coronary ectasia","volume":"130","author":"Antoniadis","year":"2008","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.gene.2024.148450_b0020","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/106145","article-title":"The levels of tumor necrosis factor-alpha and interleukin-6 in patients with isolated coronary artery ectasia","volume":"2009","author":"Aydin","year":"2009","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.gene.2024.148450_b0025","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/gtmb.2011.0077","article-title":"Associations of receptor for advanced glycation end products -374 t\/a and Gly82 ser and peroxisome proliferator-activated receptor gamma Pro12Ala polymorphisms in turkish coronary artery disease patients","volume":"16","author":"Aydogan","year":"2012","journal-title":"Genet. Test. Mol. Biomarkers."},{"issue":"3","key":"10.1016\/j.gene.2024.148450_b0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s11239-011-0668-4","article-title":"The association between soluble lectin-like oxidized low-density lipoprotein receptor-1 levels and patients with isolated coronary artery ectasia","volume":"33","author":"Balin","year":"2012","journal-title":"J. Thromb. Thrombolysis."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1161\/ATVBAHA.120.315421","article-title":"Role of LOX-1 (lectin-like oxidized low-density lipoprotein receptor 1) as a Cardiovascular risk predictor: mechanistic insight and potential clinical use","volume":"41","author":"Barreto","year":"2021","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"11","key":"10.1016\/j.gene.2024.148450_b0040","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s00109-005-0688-7","article-title":"Understanding RAGE, the receptor for advanced glycation end products","volume":"83","author":"Bierhaus","year":"2005","journal-title":"J. Mol. Med."},{"issue":"5","key":"10.1016\/j.gene.2024.148450_b0045","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/MCA.0b013e32833b20da","article-title":"Coronary artery ectasia: remains a clinical dilemma","volume":"21","author":"Boles","year":"2010","journal-title":"Coron. Artery Dis."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0050","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3390\/ijms19010260","article-title":"Cytokine disturbances in Coronary artery ectasia do not support atherosclerosis pathogenesis","volume":"19","author":"Boles","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"22","key":"10.1016\/j.gene.2024.148450_b0055","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1161\/01.CIR.0000039325.03698.36","article-title":"RAGE blockade stabilizes established atherosclerosis in diabetic apolipoprotein E-null mice","volume":"106","author":"Bucciarelli","year":"2002","journal-title":"Circulation."},{"issue":"7","key":"10.1016\/j.gene.2024.148450_b0060","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1161\/01.ATV.0000131783.74034.97","article-title":"Morphologic findings of coronary atherosclerotic plaques in diabetics: a postmortem study","volume":"24","author":"Burke","year":"2004","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0070","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5114\/aoms.2015.51412","article-title":"Association between soluble lectin-like oxidized low-density lipoprotein receptor 1 levels and coronary slow flow phenomenon","volume":"12","author":"Caglar","year":"2016","journal-title":"Arch. Med. Sci."},{"issue":"4","key":"10.1016\/j.gene.2024.148450_b0075","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1161\/01.ATV.20.4.1107","article-title":"Increased expression of lectin-like oxidized low density lipoprotein receptor-1 in initial atherosclerotic lesions of watanabe heritable hyperlipidemic rabbits","volume":"20","author":"Chen","year":"2000","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"4","key":"10.1016\/j.gene.2024.148450_b0080","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1006\/bbrc.2001.5674","article-title":"Diabetes enhances lectin-like oxidized LDL receptor-1 (LOX-1) expression in the vascular endothelium: possible role of LOX-1 ligand and AGE","volume":"287","author":"Chen","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0085","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.ijcard.2007.10.047","article-title":"Association between endogenous secretory RAGE, inflammatory markers and arterial stiffness","volume":"132","author":"Choi","year":"2009","journal-title":"Int. J. Cardiol."},{"issue":"10","key":"10.1016\/j.gene.2024.148450_b0090","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1210\/jc.2012-1951","article-title":"Effects of exercise on sRAGE levels and cardiometabolic risk factors in patients with type 2 diabetes: a randomized controlled trial","volume":"97","author":"Choi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.gene.2024.148450_b0095","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/jcla.21748","article-title":"Soluble lectin-like oxidized LDL receptor 1 as a possible mediator of endothelial dysfunction in patients with metabolic syndrome","volume":"29","author":"Civelek","year":"2015","journal-title":"J. Clin. Lab. Anal."},{"issue":"2","key":"10.1016\/j.gene.2024.148450_b0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/1755-5922.12106","article-title":"Coronary artery ectasia in atherosclerotic coronary artery disease, inflammatory disorders, and sickle cell disease","volume":"33","author":"Dahhan","year":"2015","journal-title":"Cardiovasc. Ther."},{"issue":"4","key":"10.1016\/j.gene.2024.148450_b0105","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/biof.1018","article-title":"An update on advanced glycation endproducts and atherosclerosis","volume":"38","author":"Del Turco","year":"2012","journal-title":"Biofactors."},{"issue":"3","key":"10.1016\/j.gene.2024.148450_b0110","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/jcpt.12139","article-title":"Effects of enalapril\/lercanidipine combination on some emerging biomarkers in cardiovascular risk stratification in hypertensive patients","volume":"39","author":"Derosa","year":"2014","journal-title":"J. Clin. Pharm. Ther."},{"issue":"4","key":"10.1016\/j.gene.2024.148450_b0115","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2174\/1573403X12666160504100159","article-title":"Coronary artery ectasia-a review of current literature","volume":"12","author":"Devabhaktuni","year":"2016","journal-title":"Curr. Cardiol. Rev."},{"issue":"2","key":"10.1016\/j.gene.2024.148450_b0120","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.ymgme.2005.02.010","article-title":"The -374A allele of the receptor for advanced glycation end products gene is associated with a decreased risk of ischemic heart disease in African-Brazilians with type 2 diabetes","volume":"85","author":"dos Santos","year":"2005","journal-title":"Mol. Genet. Metab."},{"issue":"6","key":"10.1016\/j.gene.2024.148450_b0125","first-page":"1061","article-title":"Relationship between the -374T\/A RAGE gene polymorphism and angiographic coronary artery disease","volume":"14","author":"Falcone","year":"2004","journal-title":"Int. J. Mol. Med."},{"issue":"5","key":"10.1016\/j.gene.2024.148450_b0130","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.ATV.0000160342.20342.00","article-title":"Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men","volume":"25","author":"Falcone","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1\u20132","key":"10.1016\/j.gene.2024.148450_b0135","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cccn.2004.11.021","article-title":"374T\/A polymorphism of the RAGE gene promoter in relation to severity of coronary atherosclerosis","volume":"354","author":"Falcone","year":"2005","journal-title":"Clin. Chim. Acta."},{"issue":"4","key":"10.1016\/j.gene.2024.148450_b0140","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1177\/039463200702000413","article-title":"The -374T\/A variant of the rage gene promoter is associated with clinical restenosis after coronary stent placement","volume":"20","author":"Falcone","year":"2007","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"3","key":"10.1016\/j.gene.2024.148450_b0145","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.arcmed.2007.11.003","article-title":"The -374T\/A RAGE polymorphism protects against future cardiac events in nondiabetic patients with coronary artery disease","volume":"39","author":"Falcone","year":"2008","journal-title":"Arch. Med. Res."},{"issue":"8","key":"10.1016\/j.gene.2024.148450_b0150","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1681\/ASN.2005010062","article-title":"Modulation of soluble receptor for advanced glycation end products by angiotensin-converting enzyme-1 inhibition in diabetic nephropathy","volume":"16","author":"Forbes","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.gene.2024.148450_b0155","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00394-009-0038-6","article-title":"Advanced glycation end products strongly activate platelets","volume":"48","author":"Gawlowski","year":"2009","journal-title":"Eur. J. Nutr."},{"issue":"6","key":"10.1016\/j.gene.2024.148450_b0160","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1161\/CIRCULATIONAHA.106.621854","article-title":"Advanced glycation end products: sparking the development of diabetic vascular injury","volume":"114","author":"Goldin","year":"2006","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.gene.2024.148450_b0165","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.imbio.2012.09.005","article-title":"The immunobiology of the receptor of advanced glycation end-products: trends and challenges","volume":"218","author":"Gonz\u00e1lez","year":"2013","journal-title":"Immunobiology."},{"issue":"5","key":"10.1016\/j.gene.2024.148450_b0170","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1474-9726.2010.00606.x","article-title":"Aldose reductase and AGE-RAGE pathways: central roles in the pathogenesis of vascular dysfunction in aging rats","volume":"9","author":"Hallam","year":"2010","journal-title":"Aging Cell."},{"key":"10.1016\/j.gene.2024.148450_b0175","doi-asserted-by":"crossref","unstructured":"Handelsman, Y., Bloomgarden, Z.T., Grunberger, G., Umpierrez, G., Zimmerman, R.S., Bailey, T.S., Blonde, L., Bray, G.A., Cohen, A.J., Dagogo-Jack, S., Davidson, J.A., Einhorn, D., Ganda, O.P., Garber, A.J., Garvey, W.T., Henry, R.R., Hirsch, I.B., Horton, E.S., Hurley, D.L., Jellinger, P.S., Jovanovi\u010d, L., Lebovitz, H.E., LeRoith, D., Levy, P., McGill, J.B., Mechanick, J.I., Mestman, J.H., Moghissi, E.S., Orzeck, E.A., Pessah-Pollack, R., Rosenblit, P.D., Vinik, A.I., Wyne, K., Zangeneh, F., 2015. American Association of Clinical Endocrinologists and American College of Endocrinology clinical practice guidelines for developing a diabetes mellitus comprehensive care plan\u20142015. Endocr. Pract. 21 (suppl 1), 1-87.","DOI":"10.4158\/EP15672.GLSUPPL"},{"issue":"48","key":"10.1016\/j.gene.2024.148450_b0180","doi-asserted-by":"crossref","first-page":"50019","DOI":"10.1074\/jbc.M409782200","article-title":"Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE)","volume":"279","author":"Hanford","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0185","doi-asserted-by":"crossref","first-page":"e013803","DOI":"10.1161\/JAHA.119.013803","article-title":"Soluble LOX-1: a novel Biomarker in patients with Coronary artery disease, stroke, and acute aortic dissection?","volume":"9","author":"Hofmann","year":"2020","journal-title":"J. Am. Heart Assoc."},{"issue":"3","key":"10.1016\/j.gene.2024.148450_b0190","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/sj.gene.6363861","article-title":"RAGE and arthritis: the G82S polymorphism amplifies the inflammatory response","volume":"3","author":"Hofmann","year":"2002","journal-title":"Genes Immun."},{"issue":"6","key":"10.1016\/j.gene.2024.148450_b0195","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.2337\/diabetes.50.6.1505","article-title":"Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy","volume":"50","author":"Hudson","year":"2001","journal-title":"Diabetes."},{"key":"10.1016\/j.gene.2024.148450_b0200","first-page":"30","article-title":"Predictive value of neutrophil to lymphocyte ratio for the presence of coronary artery ectasia in patients with aortic aneurysms","volume":"4","author":"Ikenaga","year":"2014","journal-title":"Int. J. Cardiol. Heart Vessel."},{"issue":"24","key":"10.1016\/j.gene.2024.148450_b0205","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1161\/01.CIR.99.24.3110","article-title":"Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions","volume":"99","author":"Kataoka","year":"1999","journal-title":"Circulation."},{"issue":"6","key":"10.1016\/j.gene.2024.148450_b0210","first-page":"949","article-title":"Associations of -374T\/A polymorphism of receptor for advanced glycation end products (RAGE) gene in turkish diabetic and non-diabetic patients with coronary artery disease","volume":"23","author":"Kucukhuseyin","year":"2009","journal-title":"In Vivo."},{"key":"10.1016\/j.gene.2024.148450_b0215","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fcvm.2019.00109","article-title":"Platelet function in aging","volume":"6","author":"Le Blanc","year":"2019","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.gene.2024.148450_b0220","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cyto.2008.12.012","article-title":"Chronic inflammatory status in patients with coronary artery ectasia","volume":"46","author":"Li","year":"2009","journal-title":"Cytokine."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0225","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1177\/0003319718782807","article-title":"Is Coronary artery ectasia a thrombotic disease?","volume":"70","author":"Liang","year":"2019","journal-title":"Angiology."},{"issue":"10","key":"10.1016\/j.gene.2024.148450_b0230","first-page":"1697","article-title":"Genetic variants in the receptor for advanced glycation end products (RAGE) gene were associated with circulating soluble RAGE level but not with renal function among asians with type 2 diabetes: a genome-wide association study","volume":"32","author":"Lim","year":"2017","journal-title":"Nephrol. Dial. Transplant."},{"issue":"4","key":"10.1016\/j.gene.2024.148450_b0235","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/S1016-3190(08)60049-X","article-title":"Coronary artery ectasia","volume":"20","author":"Lin","year":"2008","journal-title":"Tzu. Chi. Med. J."},{"issue":"11","key":"10.1016\/j.gene.2024.148450_b0240","doi-asserted-by":"crossref","first-page":"6097","DOI":"10.1007\/s11033-013-2721-1","article-title":"Association between the receptor for advanced glycation end products gene polymorphisms and coronary artery disease","volume":"40","author":"Liu","year":"2013","journal-title":"Mol. Biol. Rep."},{"issue":"5","key":"10.1016\/j.gene.2024.148450_b0245","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/gt.2011.133","article-title":"LOX-1 abrogation reduces cardiac hypertrophy and collagen accumulation following chronic ischemia in the mouse","volume":"19","author":"Lu","year":"2012","journal-title":"Gene Ther."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0250","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/iji.12077","article-title":"HLA class III genes involvement in Kawasaki disease: a case-control study in caucasian population","volume":"41","author":"Maggioli","year":"2014","journal-title":"Int. J. Immunogenet."},{"issue":"2","key":"10.1016\/j.gene.2024.148450_b0255","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.atherosclerosis.2009.06.003","article-title":"Receptor for advanced glycation end products (RAGE) and its inflammatory ligand EN-RAGE in non-diabetic subjects with pre-mature coronary artery disease","volume":"207","author":"Mahajan","year":"2009","journal-title":"Atherosclerosis."},{"issue":"2","key":"10.1016\/j.gene.2024.148450_b0260","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0002-9149(76)90315-5","article-title":"Clinical significance of coronary arterial ectasia","volume":"37","author":"Markis","year":"1976","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.gene.2024.148450_b0265","doi-asserted-by":"crossref","first-page":"e009874","DOI":"10.1161\/JAHA.118.009874","article-title":"High levels of soluble lectinlike oxidized low-density lipoprotein Receptor-1 are associated with carotid plaque inflammation and increased risk of ischemic stroke","volume":"8","author":"Markstad","year":"2019","journal-title":"J. Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.gene.2024.148450_b0270","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.bbrc.2010.06.093","article-title":"Nifedipine inhibits advanced glycation end products (AGEs) and their receptor (RAGE) interaction-mediated proximal tubular cell injury via peroxisome proliferator-activated receptor\u2013gamma activation","volume":"398","author":"Matsui","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0275","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0031-1272552","article-title":"Inverse association between Cardiac troponin-I and soluble receptor for advanced glycation end products in patients with non-ST-segment elevation Myocardial Infarction","volume":"20","author":"McNair","year":"2011","journal-title":"Int. J. Angiol."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0280","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.cardiores.2005.09.006","article-title":"Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders","volume":"69","author":"Mehta","year":"2006","journal-title":"Cardiovasc. Res."},{"issue":"4","key":"10.1016\/j.gene.2024.148450_b0285","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5045\/br.2018.53.4.269","article-title":"Comparison of mean platelet volume levels in coronary artery ectasia and healthy people: systematic review and meta-analysis","volume":"53","author":"Moghadam","year":"2018","journal-title":"Blood Res."},{"issue":"3","key":"10.1016\/j.gene.2024.148450_b0290","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1006\/bbrc.1997.7176","article-title":"Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats","volume":"237","author":"Nagase","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.gene.2024.148450_b0295","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.mvr.2005.10.002","article-title":"Telmisartan inhibits expression of a receptor for advanced glycation end products (RAGE) in angiotensin-II-exposed endothelial cells and decreases serum levels of soluble RAGE in patients with essential hypertension","volume":"70","author":"Nakamura","year":"2005","journal-title":"Microvasc. Res."},{"issue":"5","key":"10.1016\/j.gene.2024.148450_b0300","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/dmrr.690","article-title":"Elevation of soluble form of receptor for advanced glycation end products (sRAGE) in diabetic subjects with coronary artery disease","volume":"23","author":"Nakamura","year":"2007","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0305","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mvr.2007.09.004","article-title":"Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes","volume":"76","author":"Nakamura","year":"2008","journal-title":"Microvasc. Res."},{"issue":"10","key":"10.1016\/j.gene.2024.148450_b0310","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/j.bbagen.2007.07.003","article-title":"De-N-glycosylation or G82S mutation of RAGE sensitizes its interaction with advanced glycation endproducts","volume":"1770","author":"Osawa","year":"2007","journal-title":"Biochim. Biophys. Acta."},{"key":"10.1016\/j.gene.2024.148450_b0315","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.carpath.2018.04.005","article-title":"Molecular and cellular insights into the pathogenesis of coronary artery ectasia","volume":"35","author":"Ozturk","year":"2018","journal-title":"Cardiovasc. Pathol."},{"key":"10.1016\/j.gene.2024.148450_b0320","doi-asserted-by":"crossref","unstructured":"Pettersson-Fernholm, K., Forsblom, C., Hudson, B.I., Perola, M., Grant, P.J., Groop, P.H.; Finn-Diane Study Group., 2003. The functional -374 T\/A RAGE gene polymorphism is associated with proteinuria and cardiovascular disease in type 1 diabetic patients. Diabetes. 52 (3), 891-894.","DOI":"10.2337\/diabetes.52.3.891"},{"issue":"5","key":"10.1016\/j.gene.2024.148450_b0325","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0300-8932(03)76902-4","article-title":"Ectasia coronaria: prevalencia, caracter\u00edsticas cl\u00ednicas y angiogr\u00e1ficas [Coronary ectasia: prevalence, and clinical and angiographic characteristics]","volume":"56","author":"Pinar Berm\u00fadez","year":"2003","journal-title":"Rev. Esp. Cardiol."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0330","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1055\/s-0040-1721813","article-title":"AGE-RAGE stress and Coronary artery disease","volume":"30","author":"Prasad","year":"2021","journal-title":"Int. J. Angiol."},{"issue":"2","key":"10.1016\/j.gene.2024.148450_b0335","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2217\/17460875.2.2.239","article-title":"The RAGE connection to diabetes and atherosclerosis: an Intertwined web of advanced glycation and inflammation","volume":"2","author":"Ramasamy","year":"2007","journal-title":"Future Lipidol."},{"key":"10.1016\/j.gene.2024.148450_b0340","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.ijbiomac.2020.10.270","article-title":"Effects of the age\/rage axis in the platelet activation","volume":"166","author":"Recabarren-Leiva","year":"2021","journal-title":"Int. J. Biol. Macromol."},{"issue":"9","key":"10.1016\/j.gene.2024.148450_b0345","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.freeradbiomed.2007.06.017","article-title":"Decreased plasma soluble RAGE in patients with hypercholesterolemia: effects of statins","volume":"43","author":"Santilli","year":"2007","journal-title":"Free Radic. Biol. Med."},{"issue":"2","key":"10.1016\/j.gene.2024.148450_b0350","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1177\/0003319713488932","article-title":"Neutrophil-to-lymphocyte ratio is associated with severity of coronary artery ectasia","volume":"65","author":"Sarli","year":"2014","journal-title":"Angiology."},{"key":"10.1016\/j.gene.2024.148450_b0355","unstructured":"Scanlon, P.J., Faxon, D.P., Audet, A.M., Carabello, B., Dehmer, G.J., Eagle, K.A., Legako, R.D., Leon, D.F., Murray, J.A., Nissen, S.E., Pepine, C.J., Watson, R.M., Ritchie, J.L., Gibbons, R.J., Cheitlin, M.D., Gardner, T.J., Garson, A.Jr., Russell, R.O.Jr., Ryan, T.J., Smith, S.C.Jr., 1999. ACC\/AHA guidelines for coronary angiography. A report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines (Committee on Coronary Angiography). Developed in collaboration with the Society for Cardiac Angiography and Interventions.J. Am. Coll. Cardiol. 33(6), 1756-1824."},{"issue":"12","key":"10.1016\/j.gene.2024.148450_b0360","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.5551\/jat.11742","article-title":"Effect of advanced glycation end products on lectin-like oxidized low density lipoprotein receptor-1 expression in endothelial cells","volume":"19","author":"Shiu","year":"2012","journal-title":"J. Atheroscler. Thromb."},{"issue":"2","key":"10.1016\/j.gene.2024.148450_b0365","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/10408363.2020.1791045","article-title":"The role of soluble receptor for advanced glycation end-products (sRAGE) in the general population and patients with diabetes mellitus with a focus on renal function and overall outcome","volume":"58","author":"Steenbeke","year":"2021","journal-title":"Crit. Rev. Clin. Lab. Sci."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0370","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/01.CIR.67.1.134","article-title":"Aneurysmal coronary artery disease","volume":"67","author":"Swaye","year":"1983","journal-title":"Circulation."},{"issue":"9","key":"10.1016\/j.gene.2024.148450_b0375","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s00125-007-0759-0","article-title":"Thiazolidinedione increases serum soluble receptor for advanced glycation end-products in type 2 diabetes","volume":"50","author":"Tan","year":"2007","journal-title":"Diabetologia."},{"issue":"5","key":"10.1016\/j.gene.2024.148450_b0380","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2143\/AC.59.5.2005226","article-title":"Plasma interleukin-6 levels are increased in coronary artery ectasia","volume":"59","author":"Tokgozoglu","year":"2004","journal-title":"Acta Cardiol."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0385","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.cyto.2013.05.003","article-title":"Coronary artery ectasia and inflammatory cytokines: link with a predominant th-2 immune response?","volume":"64","author":"Triantafyllis","year":"2013","journal-title":"Cytokine."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0390","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00019501-200502000-00009","article-title":"Plasma soluble adhesion molecules; intercellular adhesion molecule-1, vascular cell adhesion molecule-1 and E-selectin levels in patients with isolated coronary artery ectasia","volume":"16","author":"Turhan","year":"2005","journal-title":"Coron. Artery Dis."},{"issue":"3","key":"10.1016\/j.gene.2024.148450_b0395","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00404-014-3457-4","article-title":"The association of lectin-like oxidized LDL receptor 1 (LOX-1) K167N and 3'UTR188CT polymorphisms with maternal plasma soluble LOX-1 levels and preeclampsia risk in Turkish population","volume":"291","author":"Tuten","year":"2015","journal-title":"Arch. Gynecol. Obstet."},{"issue":"8","key":"10.1016\/j.gene.2024.148450_b0400","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3390\/jcm7080197","article-title":"Anti-hypertensive Medication use, soluble receptor for glycation end products and risk of pancreatic cancer in the Women's health initiative study","volume":"7","author":"Wang","year":"2018","journal-title":"J. Clin. Med."},{"issue":"12","key":"10.1016\/j.gene.2024.148450_b0405","doi-asserted-by":"crossref","first-page":"e50790","DOI":"10.1371\/journal.pone.0050790","article-title":"Meta-analysis of RAGE gene polymorphism and coronary heart disease risk","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0410","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.atherosclerosis.2005.06.013","article-title":"RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes","volume":"185","author":"Wendt","year":"2006","journal-title":"Atherosclerosis."},{"issue":"4","key":"10.1016\/j.gene.2024.148450_b0415","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.2741\/e178","article-title":"Soluble form of a receptor for advanced glycation end products (sRAGE) as a biomarker","volume":"2","author":"Yamagishi","year":"2010","journal-title":"Front. Biosci. (elite Ed)"},{"key":"10.1016\/j.gene.2024.148450_b0420","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00392-007-0521-0","article-title":"Coronary artery ectasia and coronary atherosclerosis","volume":"96","author":"Yetkin","year":"2007","journal-title":"Clin. Res. Cardiol."},{"issue":"6","key":"10.1016\/j.gene.2024.148450_b0425","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1177\/0300060516664637","article-title":"Could neutrophil\/lymphocyte ratio be an indicator of coronary artery disease, coronary artery ectasia and coronary slow flow?","volume":"44","author":"Yilmaz","year":"2016","journal-title":"J. Int. Med. Res."},{"issue":"3","key":"10.1016\/j.gene.2024.148450_b0430","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000091414","article-title":"Plasma soluble adhesion molecule levels in coronary artery ectasia","volume":"105","author":"Yilmaz","year":"2006","journal-title":"Cardiology."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0435","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.1038\/s41598-021-85312-4","article-title":"RAGE ligands stimulate angiotensin II type I receptor (AT1) via RAGE\/AT1 complex on the cell membrane","volume":"11","author":"Yokoyama","year":"2021","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.gene.2024.148450_b0440","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1161\/01.STR.0000226994.93914.6c","article-title":"Polymorphisms in the advanced glycosylation end product-specific receptor gene and risk of incident myocardial infarction or ischemic stroke","volume":"37","author":"Zee","year":"2006","journal-title":"Stroke."},{"issue":"1","key":"10.1016\/j.gene.2024.148450_b0445","doi-asserted-by":"crossref","DOI":"10.11613\/BM.2019.010705","article-title":"Higher serum lectin-like oxidized low-density lipoprotein receptor-1 in patients with stable coronary artery disease is associated with major adverse cardiovascular events: a multicentre pilot study","volume":"29","author":"Zhao","year":"2019","journal-title":"Biochem. Med. (zagreb)"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111924003317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111924003317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T21:02:34Z","timestamp":1731704554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111924003317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":88,"alternative-id":["S0378111924003317"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2024.148450","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptor for advanced glycation end products polymorphisms in coronary artery ectasia","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2024.148450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"148450"}}